Gerovital H3 tablets and genuine Gerovital H3 injections signed by Ana Aslan

CERVUGID Ovules - HPV High Risk, Cervical Dysplasia Treatment - pack 3 boxes (36 ovules)
CERVUGID Ovules - HPV High Risk, Cervical Dysplasia Treatment - pack 3 boxes (36 ovules)
  • Load image into Gallery viewer, CERVUGID Ovules - HPV High Risk, Cervical Dysplasia Treatment - pack 3 boxes (36 ovules)
  • Load image into Gallery viewer, CERVUGID Ovules - HPV High Risk, Cervical Dysplasia Treatment - pack 3 boxes (36 ovules)

CERVUGID Ovules - HPV High Risk, Cervical Dysplasia Treatment - pack 3 boxes (36 ovules)

Regular price
€210,00
Sale price
€210,00
Regular price
Sold out
Unit price
per 
Tax included. Shipping calculated at checkout.

CERVUGID OVULES - HPV High Risk and Cervical Dysplasia - pack of 3 boxes - 36 ovules - 210 US$/EURO

For invoice Contact us: sales@gerovital-gh3.com

Whatsapp: +40723141550 Bucharest, Romania (Europe)

CERVUGID Ovules Treatment  is indicated in cervico-vaginal inflammatory processes (vaginitis, cervicitis), in pelvic inflammatory congestions (pelviperitonitis, adnexitis, metritis, pelvic cellulitis, inflammatory processes accompanying benign or malignant tumor formations). 

A special efficiency was also observed in the treatment of vaginal ulcerations of an inflammatory nature, which in over 90% of cases epithelize after only 2-3 treatments. Cervugid Ovules are indicated in the preoperative preparation of various genital diseases, a situation in which they ensure a favorable evolution, without infectious complications. They have also proven to be particularly useful for menopausal women who have local disorders (burns, discomfort, stress urinary incontinence, etc.).

The CERVUGID Formula is particularly effective, having very high concentrations of active substances, which are released immediately after application and covers all the causes that can cause cervico-vaginal infections and internal genital inflammation: microbial germs, mycoses, protozoa, as well as a group of inframicrobial agents - chlamydia, mycoplasmas and rickets.

In the case of CERVUGID, the success of the treatment consists in the fact that relapses no longer occur. In addition, an increase in local defense power is achieved, thus preventing infection with HPV (the human papilloma virus), proven and recognized as the etiological agent of cervical cancer. A very large percentage of young women up to 20-25 years old have this virus, which is transmitted through sexual contact. The virus lives in the cells of the cervical mucosa and causes precancerous morphological changes. The women in whom these changes were detected and who were treated with CERVUGID during the analysis no longer presented precancerous changes. It was a surprise for us too.

Composition and way of presentation

Each gynecological ovule contains: Chloramphenicol 200mg, Metronidazole 500mg, Nystatin 150mg, Hydrocotisone Acetate 15mg, lipex 403 2135mg.

Box with 12 gynecological ovules in PVC blisters.

Contraindications

Cervugid is contraindicated in pregnancy and breastfeeding, severe renal and hepatic insufficiency.

Administration

1 gynecological ovule per day in the evening before going to bed intravaginally.


Active substance: Chloramphenicol/Metronidazole/Nystatin/Hydrocortisone Acetate.

Class ATC genitourinary system> Gynecological anti-infectives and antiseptics> infectives / antiseptic - antibiotic 

Disorders: to treat or prevent vaginal infections and cervical caused by micro-organisms 

Therapeutic Action: antiinfectives / antiseptics, antibiotics 

Format: ovules (pessaries - vaginal suppository)

Manufacturer: IRCON Romania


What is Cervugid and how it is used 

This drug is used to treat or prevent vaginal infections and cervical caused by micro-organisms. 

Indications are: 

Treatment of Human Papilloma Virus (HPV) high risk and low risk.

Treatment of vaginitis and cervicitis caused by aerobic and anaerobic bacteria (including Clostridium spp.), Gram-positive or Gram-negative 

Treatment of vaginitis caused by Trichomonas vaginalis and cervicitis in combination with other micro-organisms; 

Treatment of vaginal and cervicitis caused by Mycoplasma spp. Or Chlamydia spp. With other types of micro-organisms; 

Treatment of vaginal fungal infections caused by Candida spp. With other types of micro-organisms; 

Mixed vaginitis treatment products, the combination of bacteria, Trichomonas vaginalis, Candida spp and Mycoplasma spp., Or Chlamydia spp; 

Vaginitis and cervicitis prophylaxis for patients undergoing treatment with systemic immunosuppressive chemotherapy or corticosteroids for patients undergoing radiotherapy;